<?xml version='1.0' encoding='utf-8'?>
<document id="18417431"><sentence text="Rapid and simultaneous determination of tacrolimus (FK506) and diltiazem in human whole blood by liquid chromatography-tandem mass spectrometry: application to a clinical drug-drug interaction study."><entity charOffset="40-50" id="DDI-PubMed.18417431.s1.e0" text="tacrolimus" /><entity charOffset="52-57" id="DDI-PubMed.18417431.s1.e1" text="FK506" /><entity charOffset="63-72" id="DDI-PubMed.18417431.s1.e2" text="diltiazem" /><pair ddi="false" e1="DDI-PubMed.18417431.s1.e0" e2="DDI-PubMed.18417431.s1.e0" /><pair ddi="false" e1="DDI-PubMed.18417431.s1.e0" e2="DDI-PubMed.18417431.s1.e1" /><pair ddi="false" e1="DDI-PubMed.18417431.s1.e0" e2="DDI-PubMed.18417431.s1.e2" /><pair ddi="false" e1="DDI-PubMed.18417431.s1.e1" e2="DDI-PubMed.18417431.s1.e1" /><pair ddi="false" e1="DDI-PubMed.18417431.s1.e1" e2="DDI-PubMed.18417431.s1.e2" /></sentence><sentence text="Tacrolimus (FK506) is a potent immunosuppressant widely used for organ transplantation patients while diltiazem (DTZ), a calcium-channel inhibitor, is often used in renal transplantation patients to prevent post-transplant hypertension"><entity charOffset="12-17" id="DDI-PubMed.18417431.s2.e0" text="FK506" /><entity charOffset="121-128" id="DDI-PubMed.18417431.s2.e1" text="calcium" /><pair ddi="false" e1="DDI-PubMed.18417431.s2.e0" e2="DDI-PubMed.18417431.s2.e0" /><pair ddi="false" e1="DDI-PubMed.18417431.s2.e0" e2="DDI-PubMed.18417431.s2.e1" /></sentence><sentence text=" However, DTZ has a significant pharmacokinetic interaction with FK506"><entity charOffset="65-70" id="DDI-PubMed.18417431.s3.e0" text="FK506" /></sentence><sentence text=" In this study, a rapid and sensitive ammonium-adduct based liquid chromatography-tandem mass spectrometry (LC/MS/MS) method has been developed and validated for the simultaneous determination of FK506 and DTZ in human whole blood using ascomycin as the internal standard (IS)"><entity charOffset="38-46" id="DDI-PubMed.18417431.s4.e0" text="ammonium" /><entity charOffset="237-246" id="DDI-PubMed.18417431.s4.e1" text="ascomycin" /><entity charOffset="196-204" id="DDI-PubMed.18417431.s4.e2" text="FK506" /><pair ddi="false" e1="DDI-PubMed.18417431.s4.e0" e2="DDI-PubMed.18417431.s4.e0" /><pair ddi="false" e1="DDI-PubMed.18417431.s4.e0" e2="DDI-PubMed.18417431.s4.e2" /><pair ddi="false" e1="DDI-PubMed.18417431.s4.e0" e2="DDI-PubMed.18417431.s4.e1" /><pair ddi="false" e1="DDI-PubMed.18417431.s4.e2" e2="DDI-PubMed.18417431.s4.e2" /><pair ddi="false" e1="DDI-PubMed.18417431.s4.e2" e2="DDI-PubMed.18417431.s4.e1" /></sentence><sentence text=" After extraction of the whole blood samples by ethyl acetate, FK506, DTZ and the IS were subjected to LC/MS/MS analysis using electro-spray positive-ion mode ionization (ESI(+))"><entity charOffset="48-61" id="DDI-PubMed.18417431.s5.e0" text="ethyl acetate" /><entity charOffset="63-68" id="DDI-PubMed.18417431.s5.e1" text="FK506" /><entity charOffset="70-73" id="DDI-PubMed.18417431.s5.e2" text="DTZ" /><pair ddi="false" e1="DDI-PubMed.18417431.s5.e0" e2="DDI-PubMed.18417431.s5.e0" /><pair ddi="false" e1="DDI-PubMed.18417431.s5.e0" e2="DDI-PubMed.18417431.s5.e1" /><pair ddi="false" e1="DDI-PubMed.18417431.s5.e0" e2="DDI-PubMed.18417431.s5.e2" /><pair ddi="false" e1="DDI-PubMed.18417431.s5.e1" e2="DDI-PubMed.18417431.s5.e1" /><pair ddi="false" e1="DDI-PubMed.18417431.s5.e1" e2="DDI-PubMed.18417431.s5.e2" /></sentence><sentence text=" Chromatographic separation was performed on a Hypersil BDS C18 column (50 mm x 2" /><sentence text="1 mm, i" /><sentence text="d" /><sentence text=", 3 microm)" /><sentence text=" The MS/MS detection was conducted by monitoring the fragmentation of 821" /><sentence text="7--&gt;768" /><sentence text="9 (m/z) for FK506, 415"><entity charOffset="12-14" id="DDI-PubMed.18417431.s12.e0" text="FK506" /></sentence><sentence text="5--&gt;310" /><sentence text="3 (m/z) for DTZ and 809"><entity charOffset="12-16" id="DDI-PubMed.18417431.s14.e0" text="DTZ" /></sentence><sentence text="8--&gt;757" /><sentence text="0 (m/z) for IS" /><sentence text=" The method had a chromatographic running time of approximately 2 min and linear calibration curves over the concentrations of 0" /><sentence text="5-200 ng/mL for FK506 and 2-250 ng/mL for DTZ"><entity charOffset="16-18" id="DDI-PubMed.18417431.s18.e0" text="FK506" /><entity charOffset="42-44" id="DDI-PubMed.18417431.s18.e1" text="DTZ" /><pair ddi="false" e1="DDI-PubMed.18417431.s18.e0" e2="DDI-PubMed.18417431.s18.e0" /><pair ddi="false" e1="DDI-PubMed.18417431.s18.e0" e2="DDI-PubMed.18417431.s18.e1" /></sentence><sentence text=" The recoveries of liquid-liquid extraction method were 58" /><sentence text="3-62" /><sentence text="6% for FK506 and 50"><entity charOffset="7-12" id="DDI-PubMed.18417431.s21.e0" text="FK506" /></sentence><sentence text="4-58" /><sentence text="8% for DTZ"><entity charOffset="7-11" id="DDI-PubMed.18417431.s23.e0" text="DTZ" /></sentence><sentence text=" The lower limit of quantification (LLOQ) of the analytical method was 0" /><sentence text="5 ng/mL for FK506 and 2 ng/mL for DTZ"><entity charOffset="12-14" id="DDI-PubMed.18417431.s25.e0" text="FK506" /><entity charOffset="34-36" id="DDI-PubMed.18417431.s25.e1" text="DTZ" /><pair ddi="false" e1="DDI-PubMed.18417431.s25.e0" e2="DDI-PubMed.18417431.s25.e0" /><pair ddi="false" e1="DDI-PubMed.18417431.s25.e0" e2="DDI-PubMed.18417431.s25.e1" /></sentence><sentence text=" The intra- and inter-day precision was less than 15% for all quality control samples at concentrations of 2, 10, and 50 ng/mL for FK506 and 5, 25, and 100 ng/mL for DTZ"><entity charOffset="131-133" id="DDI-PubMed.18417431.s26.e0" text="FK506" /><entity charOffset="166-168" id="DDI-PubMed.18417431.s26.e1" text="DTZ" /><pair ddi="false" e1="DDI-PubMed.18417431.s26.e0" e2="DDI-PubMed.18417431.s26.e0" /><pair ddi="false" e1="DDI-PubMed.18417431.s26.e0" e2="DDI-PubMed.18417431.s26.e1" /></sentence><sentence text=" The validated LC/MS/MS method has been successfully used to analyze the concentrations of FK506 and DTZ in whole blood samples from pharmacokinetic studies in renal transplanted patients"><entity charOffset="91-93" id="DDI-PubMed.18417431.s27.e0" text="FK506" /><entity charOffset="101-103" id="DDI-PubMed.18417431.s27.e1" text="DTZ" /><pair ddi="false" e1="DDI-PubMed.18417431.s27.e0" e2="DDI-PubMed.18417431.s27.e0" /><pair ddi="false" e1="DDI-PubMed.18417431.s27.e0" e2="DDI-PubMed.18417431.s27.e1" /></sentence><sentence text="" /></document>